In The News View All

  • Patients with Recent Acute Coronary Syndrome and Polyvascular Disease Deriv...
    AbstractBackgroundPatients with acute coronary syndrome (ACS) and concomitant noncoronary atherosclerosis have a high risk of major adverse cardiovascular events (MACE) and death. The impact of lipid-lowering by proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibition in such patients is undetermined.ObjectivesThis pre-specified ...
    Published on 2019-03-15

Authors